Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis

MLA

Roman Zenouzi, et al. “Patient Selection Based on Treatment Duration and Liver Biochemistry Increases Success Rates after Treatment Withdrawal in Autoimmune Hepatitis.” Journal of Hepatology, vol. 62, no. 3, Feb. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9b4dd838ef6a50894eb66682c7b28afc&authtype=sso&custid=ns315887.

APA

Roman Zenouzi, Benno Kreuels, C Glaubke, Johannes Hartl, Christina Weiler-Normann, Ansgar W. Lohse, Hanno Ehlken, N Pannicke, Christoph Schramm, & Marcial Sebode. (2014). Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. Journal of Hepatology, 62(3).

Chicago

Roman Zenouzi, Benno Kreuels, C Glaubke, Johannes Hartl, Christina Weiler-Normann, Ansgar W. Lohse, Hanno Ehlken, N Pannicke, Christoph Schramm, and Marcial Sebode. 2014. “Patient Selection Based on Treatment Duration and Liver Biochemistry Increases Success Rates after Treatment Withdrawal in Autoimmune Hepatitis.” Journal of Hepatology 62 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9b4dd838ef6a50894eb66682c7b28afc&authtype=sso&custid=ns315887.